Table II.
Treatment of central nervous system lymphoma following primary pathological diagnosis.
Case no. | Treatment | Clinical course | Time before progression | Secondary pathological diagnosis (method) | Follow-up prognosis |
---|---|---|---|---|---|
1 | None | Remission of primary lesion, but a later appearance of other multiple lesions | 4 months | DLBCL (biopsy) | No information |
2 | Steroid | Remission, but later appearances of other multiple lesions | 24 months | DLBCL (biopsy) | No information |
3 | Steroid | Remission, but later appearances of right frontal lesion | 11 months | DLBCL (biopsy) | No information |
4 | None | Remission of primary lesions, but later the clinical condition progressively deteriorated | No information | Poorly differentiated malignant lymphoma (autopsy) | Succumbed 4 months after initial presentation |
5 | None | Remission of primary lesions, then a slow deterioration of the patient’s condition | No information | Malignant undifferentiated lymphoma (autopsy) | Succumbed 3 months after inital presentation |
6 | None | Remission of primary lesions, patient was treated with steroids and radiotherapy following biopsy | No progression | Malignant lymphoma (autopsy) | Alive 4 years after initial diagnosis |
7 | Steroid | Remission of primary lesions, but later the clinical condition progressively deteriorated | 3 months | DLBCL (biopsy) | Succumbed 8 months after initial diagnosis |
DLBCL, diffuse large B-cell lymphoma.